دورية أكاديمية
Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study
| العنوان: | Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study |
|---|---|
| المؤلفون: | Yamashita, Toshinari, Sohn, Joo Hyuk, Tokunaga, Eriko, Niikura, Naoki, Park, Yeon Hee, Lee, Keun Seok, Chae, Yee Soo, Xu, Binghe, Wang, Xiaojia, Im, Seock-Ah, Li, Wei, Lu, Yen-Shen, Aguilar, Cecilia Orbegoso, Nishijima, Soichiro, Nishiyama, Yuji, Sugihara, Masahiro, Modi, Shanu, Tsurutani, JunjiAff16, Aff17, IDs12282024016007_cor18 |
| المصدر: | Breast Cancer. :1-11 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 13406868 18804233 |
|---|---|
| DOI: | 10.1007/s12282-024-01600-7 |